Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Barbara Maria Colombo"'
Autor:
Domenico Plantone, Matteo Pardini, Delia Righi, Carlo Manco, Barbara Maria Colombo, Nicola De Stefano
Publikováno v:
Cells, Vol 13, Iss 1, p 54 (2023)
This review analyzes the role of TNF-α and its increase in biological fluids in mild cognitive impairment, and Alzheimer’s disease (AD). The potential inhibition of TNF-α with pharmacological strategies paves the way for preventing AD and improvi
Externí odkaz:
https://doaj.org/article/18f62262110c442fbf57440e86ffa4af
Autor:
Giorgia Ferrari, Emanuele Gotelli, Sabrina Paolino, Giampaola Pesce, Luca Nanni, Barbara Maria Colombo, Greta Pacini, Carlotta Schenone, Carmen Pizzorni, Alberto Sulli, Vanessa Smith, Maurizio Cutolo
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-8 (2021)
Abstract Background Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by specific vascular and obstetric manifestations and by antiphospholipid antibodies (aPL) positivity. Microvascular damage in the course of APS and
Externí odkaz:
https://doaj.org/article/9d3c7d1414a448ee93271aaee53ee6d8
Autor:
Barbara Maria Colombo, Flavio Nobili, Federico Carbone, Alessandro Poggi, Fabrizio Montecucco, Fabio Cacciapaglia, Antonella Afeltra, Tiziano Moccetti
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 30:1147-1151
Background and aim Systemic lupus erythematosus (SLE) is associated with accelerated atherogenesis. Traditional risk factors do not seem to fully explain this process in patients with SLE and no other imaging/serum biomarkers have so far improved ris
Autor:
Antonella Afeltra, Federico Carbone, Flavio Nobili, Barbara Maria Colombo, Alessandro Poggi, Fabio Cacciapaglia, Tiziano Moccetti, Franco Dallegri, Fabrizio Montecucco
Publikováno v:
European Journal of Clinical Investigation. 49:e13089
Background Ultrasound evaluation of carotid intima-media thickness (cIMT) has been extensively used for potentially improving cardiovascular (CV) risk stratification in several patients' categories. Subjects with systemic lupus erythematosus (SLE) ha
Publikováno v:
International Journal of Immunopathology and Pharmacology. 22:557-565
The ongoing progresses in the knowledge of the pathogenic mechanisms of various inflammatory or immune-mediated diseases and the availability of innovative biotechnological approaches have lead to the development of new drugs which add to conventiona
Autor:
Giuseppe Murdaca, Barbara Maria Colombo, Gialuigi L. Marseglia, Mara De Amici, Giorgio Ciprandi
Publikováno v:
Human Immunology. 69:510-512
Allergic rhinitis (AR) is characterized by an inflammatory reaction sustained by Th2 polarization, whereas systemic lupus erythematosus (SLE) is a typical autoimmune disorder. Vascular endothelial growth factor (VEGF) is a critical mediator of inflam
Autor:
Ottavia Magnani, Alessandro Poggi, Paolo Canevali, Edoardo Rossi, Barbara Maria Colombo, Maria Raffaella Zocchi, Francesco Puppo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 2, p e31903 (2012)
PLoS ONE, Vol 7, Iss 2, p e31903 (2012)
Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies and dysregulation of B cell function. The leukocyte associated Immunoglobulin (Ig)-like receptor (LAIR)1 is a transmembrane molecule belonging to
Tumor necrosis factor (TNF)-α plays a central role in psoriatic arthritis (PsA). A subgroup of patients with PsA do not respond to anti-TNF-α antibodies but respond to TNF receptor p75-Fc IgG fusion protein (etanercept), which also neutralizes lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb24b388a955a4d9ca5f491e6bc8b49e
https://hdl.handle.net/11567/319848
https://hdl.handle.net/11567/319848
Autor:
Paola Cagnati, Giuseppe Murdaca, Francesca Spanò, Barbara Maria Colombo, Rossella Gulli, Francesco Puppo
Rheumatic autoimmune diseases have been associated with accelerated atherosclerosis and various types of vasculopathies. Atherosclerosis is an inflammatory condition which starts as a "response to injury" favoring endothelial dysfunction which is ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dfdefeec978f9ec54f00e219b9256ba
http://hdl.handle.net/11567/377889
http://hdl.handle.net/11567/377889
Autor:
Paola Cagnati, Francesca Spanò, Barbara Maria Colombo, Giuseppe Murdaca, Rossella Gulli, Francesco Puppo
Publikováno v:
Expert opinion on drug safety. 11(1)
The ongoing progresses in the knowledge of the pathogenic mechanisms of various immune-mediated and inflammatory diseases as well as the availability of innovative biotechnological approaches have led to the development of new drugs that add to conve